Related Experiment Video
Updated: Sep 1, 2025

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples
Published on: May 10, 2017
The role of SPDEF in cancer: promoter or suppressor
1Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Abstract:
SPDEF, as a member of the ETS transcription factor family, was found to play important roles not only in some normal organs but also in some cancers. Scientists found that the significant increase of SPDEF in some cancers promotes tumor development, while some others found that the expression of SPDEF is lost in some cancers, and the loss of SPDEF is related to the proliferation, invasion, and metastasis. In this review, we summarized the function of SPDEF in normal tissues and its dual behaviors in different cancers, which may become a novel target in the diagnosis and therapy of cancers in the future. Besides, the multi-upstream regulatory mechanism of SPDEF plays different regulatory roles in different tumors, deserving further study. Moreover, there is one research, reporting that SPDEF plays a role in promoting mucus production during viral infection, and this may provide new ideas for future research about virus-associated cancer.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Survival Analysis

